title: Regional postprandial fatty acid metabolism in different obesity phenotypes.
abstract: To examine if postprandial splanchnic/hepatic free fatty acid (FFA) delivery is increased in upper-body (UB) obesity, and to determine the adipose tissue depots responsible for the greater postprandial FFA availability, we measured systemic and regional uptake and release of FFAs ([1-(14)C]palmitate) before and during a 5-h frequent-feeding mixed meal in eight UB and eight lower-body (LB) obese women. Postabsorptive FFA flux and splanchnic FFA delivery were not different in UB and LB obese women; however, postprandial FFA concentrations (257 +/- 45 vs. 81 +/- 12 micromol/l, P < 0.0001), FFA flux (8.5 +/- 1.2 vs. 3.9 +/- 0.8 micromol x kg(-1) fat-free mass x min(-1), P < 0.0001), splanchnic FFA delivery (275 +/- 45 vs. 88 +/- 24 micromol/min, respectively, P < 0.005), and estimated hepatic FFA delivery were greater in UB than LB obese women. Nonsplanchnic UB adipose tissue FFA release was greater in UB than in LB obese women (276 +/- 71 vs. 97 +/- 37 micromol/min, respectively, P < 0.05) and accounted for the greater postprandial FFA availability in UB obesity. Postprandial leg glucose uptake was less in UB than in LB obese women (8.4 +/- 5.1 vs. 22.9 +/- 2.6 micromol x kg(-1) leg fat-free mass x min(-1), P < 0.05). We conclude that the elevated postprandial FFA release observed in UB obese women originates from the nonsplanchnic UB fat, not visceral fat. These results suggest that visceral fat may be a marker for, but not the source of, excess postprandial FFAs in obesity.
authors.affiliation: Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905, USA.
authors.forename: Z
authors.initials: Z
authors.lastname: Guo
authors.forename: D D
authors.initials: DD
authors.lastname: Hensrud
authors.forename: C M
authors.initials: CM
authors.lastname: Johnson
authors.forename: M D
authors.initials: MD
authors.lastname: Jensen
mesh_terms: D000328:Adult; D001682:Biological Availability; D001786:Blood Glucose / Q000032:analysis; D002395:Catecholamines / Q000097:blood; D002914:Chylomicrons / Q000378:metabolism; D004435:Eating / Q000502:physiology*; D005230:Fatty Acids, Nonesterified / Q000097:blood / Q000378:metabolism*; D005260:Female; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000097:blood; D007700:Kinetics; D007866:Leg / Q000098:blood supply; D008875:Middle Aged; D009765:Obesity / Q000235:genetics* / Q000378:metabolism* / Q000503:physiopathology; D010641:Phenotype; D012039:Regional Blood Flow / Q000502:physiology; D014280:Triglycerides / Q000378:metabolism
chemical_list: D001786:Blood Glucose; D002395:Catecholamines; D002914:Chylomicrons; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D014280:Triglycerides; D005947:Glucose